肾小球疾病治疗最新进展

[1] Management of idiopathic membranous nephropathy:evidence-based recommendations. Muirhead N. Kidney International . 1999

[2] Management of IgA nephropathy: evidencebased recommendations. Nolin L,Courteau M. Kidney International . 1999

[3] A prospective clinical trial comparing the treatment of idiopathic membranoues nephropathy and nephrotic syndrome with simvastatin and diet, verses diet alone. Rayher BL,Byrne MJ. Clinical Nephrology . 1996

[4] Effects of hypertension and dyslipdemia on the decline in renal function. Manttari M,Tiula E,AlikoskiT,et al. Journal of Hypertension . 1995

[5] Management of minimal lesion glomerulonephritis: evidence-based recommendations. Bargman JM. Kidney International . 1999

[6] Angiotensin convertine enzyme inhibitors in nondiabetic renal disease. Maschio and Marcntoni. Current Opinion in Nephrology and Hypertension . 1998

[7] Conservative treatment to slow deterioration of renal function: evidence-based recommendations. Bugess E. Kidney International . 1999

[8] Management of focal segmental glomerulosclerosis: evidence- based recommendations. Burgess E. Kidney International . 1999

[9] Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence - based recommendations. Jindal kk. Kidney International . 1999

[10] Mangement of membranoproliferative glomerulonephritis:evidence-based recommendations. Levin A. Kidney International . 1999

[1] Management of idiopathic membranous nephropathy:evidence-based recommendations. Muirhead N. Kidney International . 1999

[2] Management of IgA nephropathy: evidencebased recommendations. Nolin L,Courteau M. Kidney International . 1999

[3] A prospective clinical trial comparing the treatment of idiopathic membranoues nephropathy and nephrotic syndrome with simvastatin and diet, verses diet alone. Rayher BL,Byrne MJ. Clinical Nephrology . 1996

[4] Effects of hypertension and dyslipdemia on the decline in renal function. Manttari M,Tiula E,AlikoskiT,et al. Journal of Hypertension . 1995

[5] Management of minimal lesion glomerulonephritis: evidence-based recommendations. Bargman JM. Kidney International . 1999

[6] Angiotensin convertine enzyme inhibitors in nondiabetic renal disease. Maschio and Marcntoni. Current Opinion in Nephrology and Hypertension . 1998

[7] Conservative treatment to slow deterioration of renal function: evidence-based recommendations. Bugess E. Kidney International . 1999

[8] Management of focal segmental glomerulosclerosis: evidence- based recommendations. Burgess E. Kidney International . 1999

[9] Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence - based recommendations. Jindal kk. Kidney International . 1999

[10] Mangement of membranoproliferative glomerulonephritis:evidence-based recommendations. Levin A. Kidney International . 1999